Ani Pharmaceuticals Stock Price History
| ANIP Stock | USD 64.35 0.52 0.80% |
Below is the normalized historical share price chart for ANI Pharmaceuticals extending back to July 24, 2001. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ANI Pharmaceuticals stands at 64.35, as last reported on the 21st of March, with the highest price reaching 65.10 and the lowest price hitting 63.69 during the day.
If you're considering investing in ANI Stock, it is important to understand the factors that can impact its price. ANI Pharmaceuticals appears to be very steady, given 3 months investment horizon. ANI Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13 % return per unit of return volatility over the last 3 months. We have found twenty-eight technical indicators for ANI Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please makes use of ANI Pharmaceuticals' Mean Deviation of 1.68, semi deviation of 1.93, and Risk Adjusted Performance of 0.0657 to double-check if our risk estimates are consistent with your expectations.
At this time, ANI Pharmaceuticals' Total Stockholder Equity is relatively stable compared to the past year. As of 03/21/2025, Common Stock Shares Outstanding is likely to grow to about 20.3 M, though Treasury Stock is likely to grow to (618.2 K). . At this time, ANI Pharmaceuticals' Price Earnings To Growth Ratio is relatively stable compared to the past year. As of 03/21/2025, Price To Free Cash Flows Ratio is likely to grow to 17.52, while Price To Sales Ratio is likely to drop 1.65. ANI Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of May 2000 | 200 Day MA 59.5261 | 50 Day MA 58.6462 | Beta 0.628 |
ANI |
Sharpe Ratio = 0.1253
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ANIP | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.57 actual daily | 22 78% of assets are more volatile |
Expected Return
| 0.32 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 9 91% of assets perform better |
Based on monthly moving average ANI Pharmaceuticals is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ANI Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 3.4621 | Enterprise Value Ebitda 30.0276 | Price Sales 2.2978 | Shares Float 15.6 M | Wall Street Target Price 81.5 |
ANI Pharmaceuticals Stock Price History Chart
There are several ways to analyze ANI Stock price data. The simplest method is using a basic ANI candlestick price chart, which shows ANI Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | March 19, 2025 | 64.87 |
| Lowest Price | December 20, 2024 | 53.35 |
ANI Pharmaceuticals March 21, 2025 Stock Price Synopsis
Various analyses of ANI Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell ANI Stock. It can be used to describe the percentage change in the price of ANI Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of ANI Stock.| ANI Pharmaceuticals Price Rate Of Daily Change | 0.99 | |
| ANI Pharmaceuticals Price Action Indicator | (0.31) | |
| ANI Pharmaceuticals Price Daily Balance Of Power | (0.37) | |
| ANI Pharmaceuticals Accumulation Distribution | 4,344 |
ANI Pharmaceuticals March 21, 2025 Stock Price Analysis
ANI Stock Price History Data
The price series of ANI Pharmaceuticals for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 11.52 with a coefficient of variation of 5.01. The prices are distributed with arithmetic mean of 57.98. The median price for the last 90 days is 58.59. The company had 1:6 stock split on 18th of July 2013.| Open | High | Low | Close | Volume | ||
| 03/20/2025 | 64.87 | 65.10 | 63.69 | 64.35 | 200,568 | |
| 03/19/2025 | 64.22 | 65.04 | 63.25 | 64.87 | 454,677 | |
| 03/18/2025 | 64.40 | 65.00 | 63.26 | 64.22 | 233,027 | |
| 03/17/2025 | 62.81 | 64.92 | 62.68 | 64.35 | 334,305 | |
| 03/14/2025 | 63.36 | 63.60 | 61.48 | 62.49 | 199,309 | |
| 03/13/2025 | 63.33 | 63.33 | 61.37 | 61.46 | 145,817 | |
| 03/12/2025 | 62.56 | 64.43 | 61.83 | 63.26 | 870,783 | |
| 03/11/2025 | 58.81 | 62.03 | 57.72 | 61.40 | 430,198 | |
| 03/10/2025 | 59.97 | 60.52 | 58.48 | 58.81 | 254,433 | |
| 03/07/2025 | 60.86 | 62.76 | 60.44 | 60.62 | 438,170 | |
| 03/06/2025 | 59.22 | 62.47 | 58.50 | 61.05 | 319,805 | |
| 03/05/2025 | 59.14 | 60.77 | 57.90 | 59.68 | 316,950 | |
| 03/04/2025 | 58.06 | 62.00 | 57.88 | 59.13 | 230,445 | |
| 03/03/2025 | 60.89 | 62.04 | 58.08 | 58.46 | 427,277 | |
| 02/28/2025 | 61.64 | 62.62 | 58.00 | 61.89 | 714,998 | |
| 02/27/2025 | 54.58 | 56.33 | 54.56 | 54.58 | 185,388 | |
| 02/26/2025 | 54.64 | 55.18 | 54.10 | 55.01 | 273,260 | |
| 02/25/2025 | 56.03 | 56.03 | 54.23 | 54.51 | 264,594 | |
| 02/24/2025 | 58.19 | 58.19 | 55.17 | 55.57 | 549,655 | |
| 02/21/2025 | 60.20 | 60.22 | 57.39 | 57.94 | 218,474 | |
| 02/20/2025 | 59.86 | 60.41 | 58.84 | 59.67 | 156,890 | |
| 02/19/2025 | 58.69 | 60.54 | 58.37 | 59.99 | 172,091 | |
| 02/18/2025 | 58.84 | 59.83 | 58.55 | 58.73 | 140,306 | |
| 02/14/2025 | 59.00 | 59.42 | 58.15 | 58.92 | 132,353 | |
| 02/13/2025 | 59.54 | 59.54 | 58.75 | 59.19 | 77,500 | |
| 02/12/2025 | 59.01 | 60.02 | 58.42 | 59.68 | 161,045 | |
| 02/11/2025 | 59.00 | 60.68 | 58.59 | 59.85 | 225,486 | |
| 02/10/2025 | 60.28 | 60.73 | 59.29 | 59.59 | 226,944 | |
| 02/07/2025 | 59.89 | 61.32 | 59.59 | 60.55 | 255,344 | |
| 02/06/2025 | 59.90 | 61.00 | 59.03 | 60.19 | 553,034 | |
| 02/05/2025 | 58.68 | 60.22 | 58.57 | 59.81 | 121,788 | |
| 02/04/2025 | 57.50 | 59.19 | 57.50 | 58.59 | 199,431 | |
| 02/03/2025 | 57.86 | 58.68 | 57.08 | 57.91 | 119,025 | |
| 01/31/2025 | 59.49 | 59.49 | 58.02 | 58.64 | 119,741 | |
| 01/30/2025 | 59.61 | 60.99 | 59.36 | 59.56 | 138,668 | |
| 01/29/2025 | 59.25 | 59.84 | 58.94 | 59.35 | 97,844 | |
| 01/28/2025 | 60.10 | 60.79 | 58.94 | 59.12 | 91,181 | |
| 01/27/2025 | 58.54 | 60.78 | 58.44 | 60.42 | 158,986 | |
| 01/24/2025 | 58.69 | 58.69 | 57.36 | 58.64 | 89,075 | |
| 01/23/2025 | 57.65 | 58.95 | 57.17 | 58.69 | 76,274 | |
| 01/22/2025 | 58.29 | 58.41 | 57.12 | 58.16 | 112,394 | |
| 01/21/2025 | 58.88 | 59.26 | 57.98 | 58.35 | 154,656 | |
| 01/17/2025 | 57.94 | 58.58 | 57.57 | 58.46 | 302,521 | |
| 01/16/2025 | 56.43 | 57.93 | 56.02 | 57.50 | 172,255 | |
| 01/15/2025 | 55.27 | 56.99 | 54.75 | 56.55 | 265,918 | |
| 01/14/2025 | 54.11 | 54.49 | 53.36 | 54.16 | 263,992 | |
| 01/13/2025 | 53.92 | 54.97 | 52.74 | 53.93 | 478,176 | |
| 01/10/2025 | 53.63 | 55.21 | 53.00 | 55.04 | 141,439 | |
| 01/08/2025 | 54.40 | 54.68 | 53.63 | 54.16 | 185,015 | |
| 01/07/2025 | 54.43 | 55.13 | 53.93 | 54.38 | 181,595 | |
| 01/06/2025 | 55.50 | 55.92 | 54.35 | 54.60 | 164,429 | |
| 01/03/2025 | 55.44 | 55.89 | 54.65 | 55.50 | 101,822 | |
| 01/02/2025 | 55.60 | 56.63 | 54.96 | 55.44 | 156,382 | |
| 12/31/2024 | 54.60 | 55.38 | 54.21 | 55.28 | 246,058 | |
| 12/30/2024 | 54.01 | 54.45 | 53.15 | 54.21 | 150,580 | |
| 12/27/2024 | 55.21 | 55.37 | 53.67 | 54.41 | 248,946 | |
| 12/26/2024 | 54.00 | 55.58 | 52.89 | 55.50 | 248,015 | |
| 12/24/2024 | 54.07 | 54.33 | 53.33 | 54.16 | 43,802 | |
| 12/23/2024 | 53.39 | 54.40 | 52.79 | 54.21 | 164,227 | |
| 12/20/2024 | 53.69 | 54.56 | 53.00 | 53.35 | 1,066,257 | |
| 12/19/2024 | 54.12 | 54.78 | 52.50 | 54.26 | 393,431 |
About ANI Pharmaceuticals Stock history
ANI Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ANI is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ANI Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ANI Pharmaceuticals stock prices may prove useful in developing a viable investing in ANI Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 19.3 M | 20.3 M | |
| Net Loss | -44.6 M | -42.3 M |
ANI Pharmaceuticals Quarterly Net Working Capital |
|
ANI Pharmaceuticals Stock Technical Analysis
ANI Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
ANI Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ANI Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of ANI Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ANI to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0657 | |||
| Jensen Alpha | 0.2411 | |||
| Total Risk Alpha | 0.377 | |||
| Sortino Ratio | 0.114 | |||
| Treynor Ratio | 0.1499 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for ANI Stock Analysis
When running ANI Pharmaceuticals' price analysis, check to measure ANI Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ANI Pharmaceuticals is operating at the current time. Most of ANI Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ANI Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ANI Pharmaceuticals' price. Additionally, you may evaluate how the addition of ANI Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.